HIV

The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.

Latest News

Man rubbing wrist | Image credit: pikselstock - stock.adobe.com
Individuals With HIV Have an Increased Risk of Osteoporosis

September 11th 2025

Bone density was found to be lower in those diagnosed with HIV vs those who were HIV-negative.

Blood donation | Image credit: New Africa - stock.adobe.com
Overall Incidence of HIV in Donated Blood Declined Despite Reduction in Deferral Periods

September 8th 2025

Molecular structure of INSTI | Image credit: Сергей Шиманович - stock.adobe.com
ACC017 Showed Safety, Tolerability When Used as Antiretroviral Therapy

September 4th 2025

HIV test | Image credit: gamjai - stock.adobe.com
Cotesting for HIV, STIs Improved Screening Practices for HIV

September 2nd 2025

Black woman HIV awareness | Image credit: AS Photo Family - stock.adobe.com
ART Adherence Linked to Patient-Centered Care From Patient-Provider Relationships

August 29th 2025

Clarifying USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP)

This discussion focuses on how to address barriers and disparities as obstacles to using PrEP, with a focus on USPSTF PrEP guidelines and ACA Part 47 for payers and providers.

This multi-stakeholder roundtable panel discussion will focus on how to address barriers and disparities as obstacles to the use of PrEP, with a focus on increased understanding and education around US Preventive Services Task Force (USPSTF) PrEP guidelines and Affordable Care Act Part 47 for payers and providers.
Continuing Medical Education
View All
September 13th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
September 13th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

Illicit drugs | Image credit: Stanislau_V - stock.adobe.com
May 2nd 2025

SDOH Domains at Risk Correlated With Substance Use in People With HIV

Julia Bonavitacola
Correlation to social drivers of health (SDOH) had an important correlation with polysubstance use.
1 expert in this video
April 30th 2025

Changing Patient Demographics in HIV and Impacts of Polypharmacy on Treatment

Sharon Walmsley, CM, MD, FRCPC
A panelist discusses how the HIV patient population has aged significantly, with the average age in their clinic now exceeding 50 years and expected to soon exceed 65 years, and how these aging patients experience more comorbidities at younger ages than the general population while their HIV becomes easier to manage with simple regimens.
1 expert in this video
April 30th 2025

HIV Viral Suppression: Clinical Significance and Impact on Patient Outcomes

Sharon Walmsley, CM, MD, FRCPC
A panelist discusses how viral suppression in HIV patients means achieving undetectable virus levels (below 50 or 20 copies per ml), which prevents immune system damage and transmission to others, summarized as "undetectable equals untransmissible" (U=U).
HIV | Image credit: reddish - stock.adobe.com
April 29th 2025

Family Dynamics, Mental Health Influence Adherence to ART

Julia Bonavitacola
Improving adherence to antiretroviral therapy (ART) in youth living with HIV requires interventions that target both family dynamics and any underlying mental illness.
Benjamin Chen, MD, PhD
April 22nd 2025

HIV Cure the Goal of Future Study Into Genetic Tagging: Benjamin K. Chen, MD, PhD

Julia Bonavitacola Benjamin K. Chen, MD, PhD
Benjamin K. Chen, MD, PhD, discussed the next steps after the results of his study in genetic tagging showed promise in targeting HIV cells.
Richard Hughes IV, JD, MPH
April 21st 2025

What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV

Julia Bonavitacola Richard Hughes IV, JD, MPH
Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Benjamin Chen, MD, PhD
April 18th 2025

Genetic Tagging Offers Promise in Identifying Latent HIV Cells: Benjamin K. Chen, MD, PhD

Julia Bonavitacola Benjamin K. Chen, MD, PhD
Benjamin Chen, MD, PhD, of the Icahn School of Medicine at Mount Sinai, discusses the implications of his new study involving genetically tagging immune cells with latent HIV.
Women with HIV | Image credit: LIGHTFIELD STUDIOS - stock.adobe.com
April 16th 2025

Poor Well-Being in HIV Associated With SDOH Adversities

Julia Bonavitacola
Women living with HIV in Canada were found to have worse wellbeing when they had adversities related to social determinants of health (SDOH).
Lynae Darbes, PhD
April 14th 2025

HIV Self-Testing Clinical Trial Results Prove Feasibility in Application

Julia Bonavitacola Maggie L. Shaw Lynae Darbes, PhD
Lynae Darbes, PhD, discusses what her research results mean when it comes to implementation of self-testing and counselling for couples vulnerable for HIV.
Bridgette Picou, LVN, ACLPN, The Well Project
April 10th 2025

Breaking Silos in HIV and Menopause Care: Bridgette Picou, LVN, ACLPN

Maggie L. Shaw Bridgette J. Picou, LVN, ACLPN
An expert on the intersection of HIV and menopause, Bridgette J. Picou, LVN, ACLPN, The Well Project, explains the importance of overcoming siloed care for women living with HIV and going through menopause.
Lynae Darbes, PhD
April 7th 2025

Home-Based Couples Testing Best When Complemented With Counseling

Julia Bonavitacola Maggie L. Shaw Lynae Darbes, PhD
Lynae Darbes, PhD, discussed the findings of her study, which found that home-based visits helped to encourage the uptake of HIV testing.
Money | Image credit: Stillfx - stock.adobe.com
April 3rd 2025

Freeze in International Funding Could Significantly Reverse Progress in HIV Treatment

Julia Bonavitacola
Countries located in sub-Saharan Africa would be most affected by all funding cuts to the international HIV response.
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center
April 1st 2025

Breaking Barriers to PrEP Uptake in Kenya: Katrina Ortblad, ScD, MPH

Maggie L. Shaw Katrina Ortblad, ScD, MPH
In part 1 of this interview with Katrina Ortblad, ScD, MPH, she addressed bridging gaps in HIV care with pharmacy-based solutions.
HIV Prevention | Image credit: Nadzeya - stock.adobe.com
March 25th 2025

Elimination of Division of HIV Prevention Could Have Consequences for HIV Response

Julia Bonavitacola
The Trump administration has expressed interest in eliminating or changing the Division of HIV Prevention in the CDC, which could introduce gaps in addressing the HIV epidemic.
PrEP | Image credit: wladimir1804 - stock.adobe.com
March 20th 2025

Elimination of HIV Prevention Division Being Considered by Trump Administration

Julia Bonavitacola
The HIV prevention division could be rolled into another department of the HHS as soon as the end of the week.
Annie Antar, MD, PhD, Johns Hopkins Medicine
March 19th 2025

Presence of HIV Can Affect Treatment of Long COVID

Julia Bonavitacola Maggie L. Shaw Annie Antar, MD, PhD
Annie Antar, MD, PhD, discusses how patients with HIV can have different and longer-lasting symptoms of COVID-19.
Annie Antar, MD, PhD, Johns Hopkins Medicine
March 18th 2025

Symptoms of Long COVID Could Affect Patients With HIV More

Julia Bonavitacola Maggie L. Shaw Annie Antar, MD, PhD
Annie Antar, MD, PhD, discusses the association between the symptoms of long COVID and HIV status.
Different forms of ART | Image credit: jarun011 - stock.adobe.com
March 12th 2025

Long-Acting Injectable Cabotegravir Effective in Both ART, PrEP

Julia Bonavitacola
Cabotegravir was found to prevent HIV acquisition as a monotherapy pre-exposure prophylaxis (PrEP) and to treat HIV as a combination antiretroviral therapy (ART) in its long-acting injectable form.
ART | Image credit: Sakdatorn - stock.adobe.com
March 12th 2025

DTG/3TC, Fostemsavir Effective as ART for Patients With HIV

Julia Bonavitacola
When patients switched to either fostemsavir or the combination of dolutegravir/lamivudine (DTG/3TC), suppression was maintained in most patients.
HIV self-test | Image credit: Courtney Haas/peopleimages.com - stock.adobe.com
March 11th 2025

Self-Testing in HIV Shows Promise in Early Studies

Julia Bonavitacola
Offering mailed self-testing for HIV encouraged patients to test themselves for HIV but requires methods of improving adherence to follow-up.
HIV | Image credit: reddish - stock.adobe.com
March 10th 2025

Global Status of HIV/AIDS Pandemic Takes Center Stage in Opening Session

Julia Bonavitacola
The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about the progress, and lack of progress, that has been made in the fight against the HIV pandemic given the current political climate.
ART | Image credit: alimyakubov - stock.adobe.com
March 4th 2025

ART Approaches Differ Depending on the Patient

Julia Bonavitacola
A survey of HIV health care providers in the US revealed the various approaches that providers took for prescribing antiretroviral therapy (ART).
Antiretroviral therapy | Image credit: Maksim G - stock.adobe.com
February 25th 2025

Dolutegravir/Lamivudine Effective in Adolescents With HIV

Julia Bonavitacola
Adolescents who are treatment-naive had promising results when using dolutegravir/lamivudine as antiretroviral therapy over 48 weeks.
HIV | Image credit: artegorov3@gmail - stock.adobe.com
February 21st 2025

Recently Arrived Migrants Less Likely to Receive HIV Treatment

Julia Bonavitacola
Engaging migrants in HIV care can help to meet the United Nations’ 95-95-95 goal in Australia.
HIV test | Image credit: jarun011 - stock.adobe.com
February 20th 2025

Older, Sexually Active High School Students More Likely to Receive HIV, STI Testing

Julia Bonavitacola
Increasing testing for both HIV and sexually transmitted infections (STIs) can help to mitigate the incidence of both in high school students.
Man with HIV | Image credit: Krakenimages.com - stock.adobe.com
February 13th 2025

Cuts to PEPFAR Spell Detrimental HIV Outcomes in South Africa

Julia Bonavitacola
HIV infections and deaths would increase dramatically should the United States cut back on funding for the President’s Emergency Plan for AIDS Relief (PEPFAR).
HIV | Image credit: RAJCREATIONZS - stock.adobe.com
February 12th 2025

Despite Increases, Gender Disparities in Life Expectancy Persist Among People With HIV

Julia Bonavitacola
An overall increase in life expectancy was observed across all individuals living with HIV but disparities between gender groups persist.
Smoky mountains | Image credit: SeanPavonePhoto - stock.adobe.com
February 6th 2025

HIV Prevention Interventions Beneficial When Delivered Through Facebook

Julia Bonavitacola
Women living in rural Appalachia who are at high-risk of HIV had effective interventions delivered through Facebook.
Pre-exposure prophylaxis | Image credit: samael334 - stock.adobe.com
February 4th 2025

Knowledge of HIV Prophylaxis Low in Pharmacy Students

Julia Bonavitacola
Pharmacy students primarily in the US had a shortage of tools to assess knowledge specifically of prophylaxis in HIV care.
Tooth | Image credit: onephoto - stock.adobe.com
January 31st 2025

Poor Oral Health Quality of Life Found in Frail Patients With HIV

Julia Bonavitacola
Patients living with HIV who were frail or prefrail had significantly poorer oral health-related quality of life compared with patients with HIV who were robust.
<12345678
...
33>

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo